Skip to content

Subarachnoid Block Versus Ultrasound Guided Transversalis Fascia Plane Block for Postoperative Analgesia of Inguinal Hernia Repair in Adults

Subarachnoid Block Versus Ultrasound Guided Transversalis Fascia Plane Block for Postoperative Analgesia of Inguinal Hernia Repair in Adults: A Randomized, Double Blinded, Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06219837
Enrollment
80
Registered
2024-01-23
Start date
2023-08-01
Completion date
2024-10-31
Last updated
2024-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Analgesia of Inguinal Hernia Repair in Adults

Brief summary

The aim of our study is to investigate the effect of the ultrasound guided transversalis fascia plane block on the postoperative opioid consumption as a part of multimodal analgesia in patients undergoing inguinal herniorrhaphy under spinal anesthesia.

Detailed description

The aim of our study is to investigate the efficacy of the ultrasound-guided transversalis fascia plane block as a postoperative analgesia as a part of multimodal analgesia in patients undergoing inguinal herniorrhaphy under spinal anesthesia. The ultrasound (US)-guided transversalis fascia plane (TFP) block was first described by Hebbard in 2009. A local anesthetic (LA) injected between the transversus abdominis muscle, and its deep investing fascia will block the anterior and the lateral branches of the T12 and L1 nerves (4). The efficacy of this block has been demonstrated in iliac crest bone graft harvesting, caesarean section and inguinal herniorrhaphy

Interventions

DRUGbupivacaine injection by ultrasound guided transversalis fascia plane block

With patients in a sitting position and after appropriate skin asepsis, a 25-G pencil-point spinal needle (Pencil Point Spinal Needle Set, Egemen International Ltd., Izmir, Turkey) will be inserted through the L3 to L4 or L4 to L5 intervertebral space and 15 mg of 0.5% hyperbaric bupivacaine (AstraZeneca Pharmaceuticals, Cambridge, United Kingdom) will be injected. Subsequently, the patients will be positioned supine.

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients undergoing inguinal herniorrhaphy. * Patients 18-60 years. * ASA I and II. * Both sexes. * Having no contraindication for spinal anesthesia or TFP block.

Exclusion criteria

* Refusal of regional anesthesia. * Infection in the back or at the site of injection for TFP block. * INR \> 1.5. * Platelet count \< 80000 per microliter of blood. * Patients known to be allergic to amide local anesthetics. * BMI greater than 35 kgm\_2. * Opioid addiction. * Have communication problems that may hinder the assessement of pain postoperative.

Design outcomes

Primary

MeasureTime frameDescription
The total amount of postoperative morphine consumption during the first 24hrs postoperative.First 24 hours postoperativeThe patients will be evaluated regarding the first demand to rescue analgesia postoperatively. The pain will be assessed by the VAS score. It will be performed in the immediate post-operative period every 15 min for the first 60 min, 2 h, 4 h, 8h, 12h, 18 and 24 h. Breakthrough pain will be defined as VAS \>4 at rest.

Countries

Egypt

Contacts

Primary ContactRabab Sabry, MD
rababsabry@hotmail.com01010792931
Backup ContactOmnia Kamel, MD
omniayehiakamel90@gmail.com01270 130326

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026